LAGUNA BEACH, Calif., Aug. 22, 2024 /PRNewswire/ — Alleva, a leading practice management platform designed for behavioral health service providers, is thrilled to announce its recent accolade of the “Best Functionality and Features” award for 2024 by GetApp. This prestigious recognition highlights Alleva’s unwavering commitment to providing superior electronic medical records (EMR), customer relationship management (CRM), revenue cycle management (RCM), and data management systems that optimize workflow, cut costs, and enhance client care.
“Receiving this award from GetApp is a testament to our dedication to offering top-notch solutions that meet the unique needs of behavioral health professionals,” said Steve McCall, CEO for Alleva. “We have always aimed to deliver a platform that not only simplifies operations but also significantly elevates the standard of care provided by our users. This recognition reaffirms our standing as a trusted advisor and expert in the field.”
The benefits provided by Alleva’s platform include:
Alleva invites healthcare professionals, behavioral health clinics, and caretakers to experience firsthand the outstanding capabilities of its award-winning platform. Interested parties are encouraged to schedule a demo to explore how Alleva can revolutionize their practice management.
About Us: Alleva is committed to being the premier provider of practice management solutions for behavioral health service providers. With a focus on innovative technology and exceptional user experience, Alleva helps professionals streamline their practices and achieve better client outcomes.
Media Contact:
Sheena Streling
sheena.streling@helloalleva.com
SOURCE Alleva
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE:…
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…
SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or…
Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in…
European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary…
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase…